STAT3 and hepatocellular carcinoma: The phosphorylation status of STAT3 correlated with the resistance of HCC cells to cetuximab treatment [21], indicating that the downregulation of pSTAT3 by CIB-6 may diminish drug resistance in HCC; however, further investigations are warranted.